Role of triglyceride-rich lipoproteins in diabetic nephropathy. - Wikidata - wikimedia - TriplyDB

Role of triglyceride-rich lipoproteins in diabetic nephropathy.

Role of triglyceride-rich lipoproteins in diabetic nephropathy.

http://www.wikidata.org/entity/Q37741779

about

Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles.Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy.Parameter adaptations during phenotype transitions in progressive diseases.Obesity in kidney disease: A heavyweight opponent.Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.The association of maximum body weight on the development of type 2 diabetes and microvascular complications: MAXWEL study.Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress.Does combined peroxisome proliferator-activated receptors-agonist and pravastatin therapy attenuate the onset of diabetes-induced experimental nephropathy?Obesity, metabolic syndrome and diabetic nephropathy Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES Study Human apolipoprotein B transgenic SHR/NDmcr-cp rats show exacerbated kidney dysfunction Microvascular Complications and Their Associated Risk Factors in Newly Diagnosed Type 2 Diabetes Mellitus Patients.Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model.FXR expression is associated with dysregulated glucose and lipid levels in the offspring kidney induced by maternal obesity.Mechanisms of bradykinin-induced expression of connective tissue growth factor and nephrin in podocytes.Association of Postbreakfast Triglyceride and Visit-to-Visit Annual Variation of Fasting Plasma Glucose with Progression of Diabetic Nephropathy in Patients with Type 2 Diabetes New therapeutic agents in diabetic nephropathy.Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFκB.Postmeal triglyceridemia and variability of HbA1c and postmeal glycemia were predictors of annual decline in estimated glomerular filtration rate in type 2 diabetic patients with different stages of nephropathy.Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy.Smoking in diabetic nephropathy: sparks in the fuel tank?Fenofibrate and the kidney: an overview.Treatment and impact of dyslipidemia in diabetic nephropathy.Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes.Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes.Prediction of drug-related problems in diabetic outpatients in a number of hospitals, using a modeling approach.Direct association of visit-to-visit HbA1c variation with annual decline in estimated glomerular filtration rate in patients with type 2 diabetes Role of triglyceride-rich lipoproteins in renal injury.Effect of edaravone in diabetes mellitus-induced nephropathy in rats.Metabolic imaging of fatty kidney in diabesity: validation and dietary intervention.A triglyceride-rich lipoprotein environment exacerbates renal injury in the accelerated nephrotoxic nephritis model.Fasting APO B48 levels are associated with microalbuminuria in patients with type 2 diabetes.Antidiabetic effect of the total polyphenolic acids fraction from Salvia miltiorrhiza Bunge in diabetic rats.Distribution of Cytotoxic T Lymphocyte-Associated Antigen-4 Promoter Polymorphisms in Taiwanese Patients with Type 2 Diabetes Mellitus.The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus.Tangshen Formula Attenuates Diabetic Nephropathy by Promoting ABCA1-Mediated Renal Cholesterol Efflux in db/db Mice.

P2860

Q30407920-9146EA73-689C-49EC-B962-A01E04C01E0F Q30992797-2D9A889C-C383-4697-B19D-46636ADCD0D0 Q33783045-9363283F-7215-41EB-B23B-7EF8D967D9DF Q34059056-B579F99F-DE2C-4B14-846A-DA754E1FDAA0 Q34367664-A87E284A-1460-4AE8-8A41-52E2087BE077 Q34427292-3D541FBA-8ABF-4252-9EEE-5C22C3E41D1F Q34718616-8E8A13F5-220A-4821-92A3-6926FA1B824D Q35063749-9C8289EC-714A-445B-BE53-12C1AD092899 Q35068358-DB68A728-EFE6-45E9-9CAD-A089AA5E8038 Q35126070-E800EB22-7AD0-4E01-A6C8-1C306E47F6C5 Q35183612-F1036087-6AB6-4D36-B498-A57DB2DB3C2F Q35224446-C966FD96-D601-487A-9F42-E50039E6659D Q35344925-4B27980B-AD17-4A9A-9144-4E1A8CD33B01 Q35992007-96C16425-8E9D-411C-BF97-771A555C53D8 Q36112535-E44941B7-01A8-4421-AD6E-B3936EDCD2A6 Q36179961-D1829C4D-E2E8-4A2E-BC65-854D5FF0D89D Q36294501-69F1B550-321F-4A19-BD26-4211594DB885 Q36345943-DC935E91-6F14-4E45-B0FF-B777758630AE Q37448563-C461E30E-D982-4D1D-9E31-B8503602159A Q37559164-D73647C9-3593-4072-96FD-A010955D1953 Q37575951-4C773229-259C-46C8-8DAD-6EF8D8EBC6B3 Q37578952-B779ED08-0A72-40A7-A2FE-88875C4BF04C Q37603244-6FAB07FD-5BB1-41DA-ADD9-611BE52257A6 Q38072702-542B5FB9-5E61-45FA-BA7F-E530C3C1B76F Q38088377-BFDAD179-D693-4425-9B96-6798D1189D93 Q38160397-4919E904-C63C-48AE-A548-327E89F9FB29 Q38160494-BBFA7A53-367C-46B8-B23F-56EF39F0B872 Q40232094-D3C51878-A40F-4FAF-AD97-727D0D7719BC Q41123351-31A7B9F7-D322-4269-900F-B6DF2DDF2DBC Q41283460-89BBB6DC-F35B-45DE-BDEE-AF2DF824AEAC Q41846923-8B80D0E6-6633-4473-82F5-17DE6EC1C087 Q42223823-B4AFE1C6-050A-4695-97BF-67C6F28B218B Q42434867-0438DD49-6A79-4BA8-BBF0-5DC5B12AF6B1 Q47676923-56690CC4-3366-4207-AA0E-9AB468E70719 Q48100272-2CB46C74-EB1E-4B62-87E2-060D2A9B8BBE Q51359468-74EA5FE9-BF72-4874-B641-2729BF278BCF Q51365152-45BEEEBA-50D9-4E92-9E6C-25DB80E77442 Q52728405-C96BEFBA-AD9F-46A4-B0AC-84FC96E24733 Q54373570-861B8A16-5563-4224-BCC4-500992C79244 Q55234574-E4B5C20C-C1F0-40FA-8D52-86605C277CF0

P2860

Role of triglyceride-rich lipoproteins in diabetic nephropathy.

http://www.wikidata.org/entity/Q37741779

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of triglyceride-rich lipoproteins in diabetic nephropathy.

@en

Role of triglyceride-rich lipoproteins in diabetic nephropathy.

@nl

type

label

Role of triglyceride-rich lipoproteins in diabetic nephropathy.

@en

Role of triglyceride-rich lipoproteins in diabetic nephropathy.

@nl

prefLabel

Role of triglyceride-rich lipoproteins in diabetic nephropathy.

@en

Role of triglyceride-rich lipoproteins in diabetic nephropathy.

@nl

P1433

Q37741779-83CF3FBE-4188-48CC-B80A-E5B714AB2E79

P1476

Q37741779-DDCD9EE6-D228-45E0-BD95-A5281592A642

P2093

Q37741779-35280214-A9D9-4A9C-9110-DAF56520605C

Q37741779-42A57F18-5F97-4799-8F52-AE6F6837A6DA

Q37741779-4FA68AB7-DB10-48FA-ACE6-69B696D84C40

Q37741779-65172BEF-576C-46EC-8BE8-8CE2D7752DFE

P2860

Q37741779-1355F16D-90B9-448B-9B3B-1470C87CF57C

Q37741779-92DAAC48-A487-45FC-9EE9-2CC4C5D02894

Q37741779-B9F4E1C2-EFBC-4B34-855A-FCA6F0E5A8A0

Q37741779-E1097783-0257-416F-AA7E-21497DE7B821

P2888

Q37741779-27F82F07-A383-4531-81E2-3B80006C5010

P304

Q37741779-23B165C0-065B-48A6-826C-38723A305C63

P31

Q37741779-15479F97-55F6-4E0B-A8A3-962703164926

P356

Q37741779-59A26F06-94E2-492A-93E0-3F31FC16BA56

P407

Q37741779-FDFC7F03-F8CC-4A52-B322-1FFB2CFA938B

P433

Q37741779-E84D8EB6-65EC-4033-B7DC-CF103C7DDC07

P478

Q37741779-B39858FC-95A4-4BED-933B-81DEC3DD8728

P577

Q37741779-EB9C0F06-96E0-4185-A92E-F0926CD5CE69

P5875

Q37741779-009DC463-5A73-4AB5-A9F6-139A0872E498

P698

Q37741779-F6FEF0C2-0CF9-4148-89A3-F609105B47CA

P921

Q37741779-8BE632D2-6B5C-4A6D-9DEB-6724FFC20AFF

Q37741779-8C5A5C23-9AC5-4BA2-99A4-2F3659E14429

P356

P1433

Nature Reviews Nephrology

P1476

Role of triglyceride-rich lipoproteins in diabetic nephropathy.

@en

P2093

Dennis W Wilson

http://www.w3.org/2001/XMLSchema#string

Hnin H Aung

http://www.w3.org/2001/XMLSchema#string

John C Rutledge

http://www.w3.org/2001/XMLSchema#string

Kit F Ng

http://www.w3.org/2001/XMLSchema#string

P2860

Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study.

The progression of renal disease.

Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice.

Oxidized lipoproteins degrade the endothelial surface layer : implications for platelet-endothelial cell adhesion.

P2888

P304

361-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEPH.2010.59

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44571155

http://www.w3.org/2001/XMLSchema#string

P698

20440276

http://www.w3.org/2001/XMLSchema#string

P921